Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse.
The pharmacological chaperone, isofagomine (IFG), enhances acid β-glucosidase (GCase) function by altering folding, trafficking, and activity in wild-type and Gaucher disease fibroblasts. The in vivo effects of IFG on GCase activity, its substrate levels, and phenotype were evaluated using a neurono...
Guardado en:
Autores principales: | Ying Sun, Huimin Ran, Benjamin Liou, Brian Quinn, Matt Zamzow, Wujuan Zhang, Jacek Bielawski, Kazuyuki Kitatani, Kenneth D R Setchell, Yusuf A Hannun, Gregory A Grabowski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07efa194c76b48e6828757b10303fbfd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Literature Review: Dental Aspects in Gaucher Disease
por: Santos,Elza Maria Carneiro Mendes Ferreira dos, et al.
Publicado: (2018) -
Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia
por: Irene Motta, et al.
Publicado: (2021) -
Review of the safety and efficacy of imiglucerase treatment of Gaucher disease
por: Deborah Elstein, et al.
Publicado: (2009) -
Gaucher Disease Type I: A Case Report
por: Nikolova D., et al.
Publicado: (2020) -
Tres casos de enfermedad de Gaucher tipo I
por: Aída Lemes, et al.
Publicado: (2006)